Human mesenchymal stem cells enhance cancer cell proliferation via IL-6 secretion and activation of ERK1/2

International Journal of Oncology

Volumn 47, Issue 1, 2015, Pages 391-397

  Scherzad, Agmal ^a   Steber, Magdalena ^a   Gehrke, Thomas ^a   Rak, Kristen ^a   Froelich, Katrin ^a   Schendzielorz, Philipp ^a   Hagen, Rudolf ^a   Kleinsasser, Norbert ^a   Hackenberg, Stephan ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cytokines; HNSCC; Human mesenchymal stem cells; IL 6; Mapk (ERK 1 2)

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOSTATIN M; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; CULTURE MEDIUM; IL6 PROTEIN, HUMAN; MAPK1 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; CELL LINE; CELL MOTION; CULTURE MEDIUM; CULTURE TECHNIQUE; CYTOLOGY; GENE EXPRESSION REGULATION; HEAD AND NECK TUMOR; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHARMACOLOGY; SECRETION (PROCESS); SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL CULTURE TECHNIQUES; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-6; MESENCHYMAL STROMAL CELLS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3;

EID: 84931035243     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3009     Document Type: Article

References (45)

1. Pittenger MF, Mackay AM, Beck S.C., Jaiswal RK, Douglas R, Mosca JD, Moorman M.A., Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147, 1999.
2. Bianco P, Riminucci M, Gronthos S and Robey PG: Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19: 180-192, 2001.
3. Coffelt SB, Marini FC, Watson K, Zwezdaryk K.J., Dembinski JL, LaMarca HL, Tomchuck SL, Honer zu Bentrup K, Danka ES, Henkle SL, et al.: The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. Proc Natl Acad Sci USA 106: 3806-3811, 2009
4. Asahara T, Masuda H, Takahashi T., Kalka C, Pastore C, Silver M., Kearne M, Magner M and Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculo-genesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999
5. Malek S, Kaplan E, Wang J.F., Ke Q., Rana JS, Chen Y, Rahim BG, Li M, Huang Q., Xiao YF, et al.: Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis. Pflugers Arch 452: 268-275, 2006.
6. Campbell JJ and Butcher EC: Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 12: 336-341, 2000.
7. - progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4 Stem Cells Dev 14: 329-336, 2005
8. Dvorak HF: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986.
9. Kidd S, Caldwell L, Dietrich M., Samudio I, Spaeth EL, Watson K, Shi Y., Abbruzzese J, Konopleva M, Andreeff M, et al.: Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by antiinflammatory treatment. Cytotherapy 12: 615-625, 2010.
10. Spaeth EL, Dembinski JL, Sasser A.K., Watson K., Klopp A, Hall B, Andreeff M and Marini F: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4: e4992, 2009
11. Huang Q, Liu XZ, Kang C.S., Wang GX, Zhong Y and Pu PY The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells. Cancer Gene Ther 17: 192-202, 2010.
12. Cavarretta IT, Altanerova V, Matuskova M., Kucerova L, Culig Z and Altaner C: Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth. Mol Ther 18: 223-231, 2010.
13. Karnoub AE, Dash AB, Vo A.P., Sullivan A., Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg RA: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563, 2007
14. Lin WR, Brittan M and Alison MR: The role of bone marrow-derived cells in fibrosis. Cells Tissues Organs 188: 178-188, 2008.
15. Rhodes LV, Muir SE, Elliott S, Guillot L.M., Antoon JW, Penfornis P, Tilghman SL, Salvo V.A., Fonseca JP, Lacey MR, et al.: Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence. Breast Cancer Res Treat 121: 293-300, 2010.
16. Kemp KC, Hows J and Donaldson C: Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 46: 1531-1544, 2005
17. Wang Y, Wang M, Abarbanell A.M., Weil BR, Herrmann JL, Tan J, Novotny N.M., Coffey AC and Meldrum DR: MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells. Surgery 146: 198-205, 2009
18. Scherzed A, Hackenberg S, Froelich K., Kessler M, Koehler C, Hagen R., Radeloff A, Friehs G and Kleinsasser N: BMSC enhance the survival of paclitaxel treated squamous cell carcinoma cells in vitro. Cancer Biol Ther 11: 349-357, 2011.
19. Park JI: Growth arrest signaling of the Raf/MEK/ERK pathway in cancer. Front Biol (Beijing) 9: 95-103, 2014
20. Whyte J, Bergin O, Bianchi A., McNally S and Martin F: Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development. Breast Cancer Res 11: 209, 2009
21. Dhillon AS, Hagan S, Rath O and Kolch W: MAP kinase signalling pathways in cancer. Oncogene 26: 3279-3290, 2007
22. Scherzed A, Hackenberg S, Radeloff A., Froelich K, Rak K, Hagen R and Kleinsasser N: Human mesenchymal stem cells promote cancer motility and cytokine secretion in vitro. Cells Tissues Organs 198: 327-337, 2013.
23. Lee RH, Kim B, Choi I., Kim H, Choi HS, Suh K, Bae YC and Jung JS: Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14: 311-324, 2004
24. Rangan SR: A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29: 117-121, 1972.
25. Zenner HP, Lehner W and Herrmann IF: Establishment of carcinoma cell lines from larynx and submandibular gland. Arch Otorhinolaryngol 225: 269-277, 1979
26. Witz IP: Tumor-microenvironment interactions: Dangerous liaisons. Adv Cancer Res 100: 203-229, 2008.
27. Zigrino P, Löffek S and Mauch C: Tumor-stroma interactions: Their role in the control of tumor cell invasion. Biochimie 87: 321-328, 2005
28. Chen Z, Malhotra PS, Thomas G.R., Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh N.T., Kroog GS, Rudy S, et al.: Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5: 1369-1379, 1999
29. Kanazawa T, Nishino H, Hasegawa M., Ohta Y, Iino Y, Ichimura K and Noda Y: Interleukin-6 directly influences proliferation and invasion potential of head and neck cancer cells. Eur Arch Otorhinolaryngol 264: 815-821, 2007
30. Lederle W, Depner S, Schnur S., Obermueller E, Catone N, Just A., Fusenig NE and Mueller MM: IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines. Int J Cancer 128: 2803-2814, 2011.
31. Cohen S, Bruchim I, Graiver D., Evron Z, Oron-Karni V, Pasmanik-Chor M, Eitan R., Bernheim J, Levavi H, Fishman A, et al.: Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2. J Mol Med Berl 91: 357-368, 2013.
32. Chang H, Shi Y, Tuokan T., Chen R and Wang X: Expression of aquaporin 8 and phosphorylation of Erkl/2 in cervical epithelial carcinogenesis: Correlation with clinicopathological parameters. Int J Clin Exp Pathol 7: 3928-3937, 2014
33. Hsu YL, Hou MF, Kuo P.L., Huang YF and Tsai EM: Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSKl/Elk-1/snail signaling pathway. Oncogene 32: 4436-4447, 2013.
34. Shi Y, Hsu JH, Hu L, Gera J and Lichtenstein A: Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6. J Biol Chem 277: 15712-15720, 2002.
35. Levy DE and Darnell JE Jr: Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662, 2002.
36. Rose-John S, Scheller J, Elson G and Jones SA: Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer. J Leukoc Biol 80: 227-236, 2006.
37. Qiao L, Xu Z, Zhao T., Zhao Z, Shi M, Zhao R.C., Ye L and Zhang X: Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res 18: 500-507, 2008.
38. Zhu Y, Sun Z, Han Q., Liao L, Wang J, Bian C., Li J, Yan X, Liu Y, Shao C, et al.: Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 23: 925-933, 2009
39. Liu R, Wei S, Chen J and Xu S: Mesenchymal stem cells in lung cancer tumor microenvironment: Their biological properties, influence on tumor growth and therapeutic implications. Cancer Lett 353: 145-152, 2014
40. Direkze NC, Hodivala-Dilke K, Jeffery R., Hunt T, Poulsom R, Oukrif D., Alison MR and Wright NA: Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64: 8492-8495, 2004
41. Mishra PJ, Mishra PJ, Humeniuk R, Medina D.J., Alexe G., Mesirov JP, Ganesan S, Glod JW and Banerjee D: Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339, 2008.
42. Silzle T, Kreutz M, Dobler M.A., Brockhoff G., Knuechel R and Kunz-Schughart LA: Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol 33: 1311-1320, 2003.
43. Koukourakis MI, Giatromanolaki A, Harris AL and Sivridis E: Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Res 66: 632-637, 2006.
44. De Wever O and Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 200: 429-447, 2003.
45. Qiao L, Xu ZL, Zhao T.J., Ye LH and Zhang XD: Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 269: 67-77, 2008.